(1)
Żelazny, P.; Filipczak, J.; Sygacz, O.; Bróż, S.; Dankiewicz, S.; Swora, A.; Borowik, J.; Brodowski, W.; Pawłowski, P.; Basta-Arciszewska, K. Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) Therapy As a New Hope in the Population of People With Heart Failure With Reduced Ejection Fraction (HFrEF). J Educ Health Sport 2022, 12, 583-588.